ZFP36 loss-mediated BARX1 stabilization promotes malignant phenotypes by transactivating master oncogenes in NSCLC

Abstract Non-small cell lung cancer (NSCLC) is the most common type of lung cancer, with high morbidity and mortality worldwide. Although the dysregulation of BARX1 expression has been shown to be associated with malignant cancers, including NSCLC, the underlying mechanism remains elusive. In this s...

Full description

Bibliographic Details
Main Authors: Tongjia Zhang, Lizhen Qiu, Jiashun Cao, Qiu Li, Lifan Zhang, Guoshun An, Juhua Ni, Hongti Jia, Shuyan Li, Kailong Li
Format: Article
Language:English
Published: Nature Publishing Group 2023-08-01
Series:Cell Death and Disease
Online Access:https://doi.org/10.1038/s41419-023-06044-z
_version_ 1797740753391190016
author Tongjia Zhang
Lizhen Qiu
Jiashun Cao
Qiu Li
Lifan Zhang
Guoshun An
Juhua Ni
Hongti Jia
Shuyan Li
Kailong Li
author_facet Tongjia Zhang
Lizhen Qiu
Jiashun Cao
Qiu Li
Lifan Zhang
Guoshun An
Juhua Ni
Hongti Jia
Shuyan Li
Kailong Li
author_sort Tongjia Zhang
collection DOAJ
description Abstract Non-small cell lung cancer (NSCLC) is the most common type of lung cancer, with high morbidity and mortality worldwide. Although the dysregulation of BARX1 expression has been shown to be associated with malignant cancers, including NSCLC, the underlying mechanism remains elusive. In this study, we identified BARX1 as a common differentially expressed gene in lung squamous cell carcinoma and adenocarcinoma. Importantly, we uncovered a novel mechanism behind the regulation of BARX1, in which ZFP36 interacted with 3’UTR of BARX1 mRNA to mediate its destabilization. Loss of ZFP36 led to the upregulation of BARX1, which further promoted the proliferation, migration and invasion of NSCLC cells. In addition, the knockdown of BARX1 inhibited tumorigenicity in mouse xenograft. We demonstrated that BARX1 promoted the malignant phenotypes by transactivating a set of master oncogenes involved in the cell cycle, DNA synthesis and metastasis. Overall, our study provides insights into the mechanism of BARX1 actions in NSCLC and aids a better understanding of NSCLC pathogenesis.
first_indexed 2024-03-12T14:16:57Z
format Article
id doaj.art-dba127c8f2274f2fb7e046c89c009018
institution Directory Open Access Journal
issn 2041-4889
language English
last_indexed 2024-03-12T14:16:57Z
publishDate 2023-08-01
publisher Nature Publishing Group
record_format Article
series Cell Death and Disease
spelling doaj.art-dba127c8f2274f2fb7e046c89c0090182023-08-20T11:22:23ZengNature Publishing GroupCell Death and Disease2041-48892023-08-0114811310.1038/s41419-023-06044-zZFP36 loss-mediated BARX1 stabilization promotes malignant phenotypes by transactivating master oncogenes in NSCLCTongjia Zhang0Lizhen Qiu1Jiashun Cao2Qiu Li3Lifan Zhang4Guoshun An5Juhua Ni6Hongti Jia7Shuyan Li8Kailong Li9Department of Biochemistry and Biophysics, Beijing Key Laboratory of Protein Posttranslational Modifications and Cell Function, School of Basic Medical Sciences, Peking University Health Science CenterDepartment of Biochemistry and Biophysics, Beijing Key Laboratory of Protein Posttranslational Modifications and Cell Function, School of Basic Medical Sciences, Peking University Health Science CenterDepartment of Thoracic Surgery, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua UniversityDepartment of Research, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua UniversityDepartment of Biochemistry and Biophysics, Beijing Key Laboratory of Protein Posttranslational Modifications and Cell Function, School of Basic Medical Sciences, Peking University Health Science CenterDepartment of Biochemistry and Biophysics, Beijing Key Laboratory of Protein Posttranslational Modifications and Cell Function, School of Basic Medical Sciences, Peking University Health Science CenterDepartment of Biochemistry and Biophysics, Beijing Key Laboratory of Protein Posttranslational Modifications and Cell Function, School of Basic Medical Sciences, Peking University Health Science CenterDepartment of Biochemistry and Biophysics, Beijing Key Laboratory of Protein Posttranslational Modifications and Cell Function, School of Basic Medical Sciences, Peking University Health Science CenterDepartment of Biochemistry and Biophysics, Beijing Key Laboratory of Protein Posttranslational Modifications and Cell Function, School of Basic Medical Sciences, Peking University Health Science CenterDepartment of Biochemistry and Biophysics, Beijing Key Laboratory of Protein Posttranslational Modifications and Cell Function, School of Basic Medical Sciences, Peking University Health Science CenterAbstract Non-small cell lung cancer (NSCLC) is the most common type of lung cancer, with high morbidity and mortality worldwide. Although the dysregulation of BARX1 expression has been shown to be associated with malignant cancers, including NSCLC, the underlying mechanism remains elusive. In this study, we identified BARX1 as a common differentially expressed gene in lung squamous cell carcinoma and adenocarcinoma. Importantly, we uncovered a novel mechanism behind the regulation of BARX1, in which ZFP36 interacted with 3’UTR of BARX1 mRNA to mediate its destabilization. Loss of ZFP36 led to the upregulation of BARX1, which further promoted the proliferation, migration and invasion of NSCLC cells. In addition, the knockdown of BARX1 inhibited tumorigenicity in mouse xenograft. We demonstrated that BARX1 promoted the malignant phenotypes by transactivating a set of master oncogenes involved in the cell cycle, DNA synthesis and metastasis. Overall, our study provides insights into the mechanism of BARX1 actions in NSCLC and aids a better understanding of NSCLC pathogenesis.https://doi.org/10.1038/s41419-023-06044-z
spellingShingle Tongjia Zhang
Lizhen Qiu
Jiashun Cao
Qiu Li
Lifan Zhang
Guoshun An
Juhua Ni
Hongti Jia
Shuyan Li
Kailong Li
ZFP36 loss-mediated BARX1 stabilization promotes malignant phenotypes by transactivating master oncogenes in NSCLC
Cell Death and Disease
title ZFP36 loss-mediated BARX1 stabilization promotes malignant phenotypes by transactivating master oncogenes in NSCLC
title_full ZFP36 loss-mediated BARX1 stabilization promotes malignant phenotypes by transactivating master oncogenes in NSCLC
title_fullStr ZFP36 loss-mediated BARX1 stabilization promotes malignant phenotypes by transactivating master oncogenes in NSCLC
title_full_unstemmed ZFP36 loss-mediated BARX1 stabilization promotes malignant phenotypes by transactivating master oncogenes in NSCLC
title_short ZFP36 loss-mediated BARX1 stabilization promotes malignant phenotypes by transactivating master oncogenes in NSCLC
title_sort zfp36 loss mediated barx1 stabilization promotes malignant phenotypes by transactivating master oncogenes in nsclc
url https://doi.org/10.1038/s41419-023-06044-z
work_keys_str_mv AT tongjiazhang zfp36lossmediatedbarx1stabilizationpromotesmalignantphenotypesbytransactivatingmasteroncogenesinnsclc
AT lizhenqiu zfp36lossmediatedbarx1stabilizationpromotesmalignantphenotypesbytransactivatingmasteroncogenesinnsclc
AT jiashuncao zfp36lossmediatedbarx1stabilizationpromotesmalignantphenotypesbytransactivatingmasteroncogenesinnsclc
AT qiuli zfp36lossmediatedbarx1stabilizationpromotesmalignantphenotypesbytransactivatingmasteroncogenesinnsclc
AT lifanzhang zfp36lossmediatedbarx1stabilizationpromotesmalignantphenotypesbytransactivatingmasteroncogenesinnsclc
AT guoshunan zfp36lossmediatedbarx1stabilizationpromotesmalignantphenotypesbytransactivatingmasteroncogenesinnsclc
AT juhuani zfp36lossmediatedbarx1stabilizationpromotesmalignantphenotypesbytransactivatingmasteroncogenesinnsclc
AT hongtijia zfp36lossmediatedbarx1stabilizationpromotesmalignantphenotypesbytransactivatingmasteroncogenesinnsclc
AT shuyanli zfp36lossmediatedbarx1stabilizationpromotesmalignantphenotypesbytransactivatingmasteroncogenesinnsclc
AT kailongli zfp36lossmediatedbarx1stabilizationpromotesmalignantphenotypesbytransactivatingmasteroncogenesinnsclc